Hop S. Tran Cao

Half-Antibody Functionalized Lipid−Polymer Hybrid Nanoparticles for Targeted Drug Delivery to Carcinoembryonic Antigen Presenting Pancreatic Cancer Cells

Che‐Ming Jack Hu, Sharmeela Kaushal, Hop S. Tran Cao et al. · Molecular Pharmaceutics · 2010 · 210 citations

Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival

Ching‐Wei D. Tzeng, Hop S. Tran Cao, Jeffrey E. Lee et al. · Journal of Gastrointestinal Surgery · 2013 · 193 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +10

A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage

George Van Buren, Mark Bloomston, Carl Schmidt et al. · Annals of Surgery · 2017 · 155 citations

Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression

Yingchun Wang, Jonathan A. Kelber, Hop S. Tran Cao et al. · Proceedings of the National Academy of Sciences · 2010 · 117 citations

Cytoskeleton, Cancer Biology, Cellular Physiology +19

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Hop S. Tran Cao, Alpana Balachandran, Huamin Wang et al. · Journal of Gastrointestinal Surgery · 2013 · 116 citations · Full text

Radiographic Tumor–vein Interface, Surgical Oncology, Tumoral Pathology +10